SIRT3 and GCN5L regulation of NADP+- and NADPH-driven reactions of mitochondrial isocitrate dehydrogenase IDH2
Language English Country Great Britain, England Media electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
32457458
PubMed Central
PMC7250847
DOI
10.1038/s41598-020-65351-z
PII: 10.1038/s41598-020-65351-z
Knihovny.cz E-resources
- MeSH
- Acetylation MeSH
- Glutarates metabolism MeSH
- Isocitrate Dehydrogenase genetics metabolism MeSH
- Isocitrates chemistry MeSH
- Humans MeSH
- Mitochondria metabolism MeSH
- Cell Line, Tumor MeSH
- NADP metabolism MeSH
- Oxidation-Reduction MeSH
- Nerve Tissue Proteins metabolism MeSH
- Sirtuin 3 metabolism MeSH
- Gene Silencing MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- alpha-hydroxyglutarate MeSH Browser
- BLOC1S1 protein, human MeSH Browser
- Glutarates MeSH
- IDH2 protein, human MeSH Browser
- Isocitrate Dehydrogenase MeSH
- Isocitrates MeSH
- isocitric acid MeSH Browser
- NADP MeSH
- Nerve Tissue Proteins MeSH
- SIRT3 protein, human MeSH Browser
- Sirtuin 3 MeSH
Wild type mitochondrial isocitrate dehydrogenase (IDH2) was previously reported to produce oncometabolite 2-hydroxyglutarate (2HG). Besides, mitochondrial deacetylase SIRT3 has been shown to regulate the oxidative function of IDH2. However, regulation of 2HG formation by SIRT3-mediated deacetylation was not investigated yet. We aimed to study mitochondrial IDH2 function in response to acetylation and deacetylation, and focus specifically on 2HG production by IDH2. We used acetylation surrogate mutant of IDH2 K413Q and assayed enzyme kinetics of oxidative decarboxylation of isocitrate, 2HG production by the enzyme, and 2HG production in cells. The purified IDH2 K413Q exhibited lower oxidative reaction rates than IDH2 WT. 2HG production by IDH2 K413Q was largely diminished at the enzymatic and cellular level, and knockdown of SIRT3 also inhibited 2HG production by IDH2. Contrary, the expression of putative mitochondrial acetylase GCN5L likely does not target IDH2. Using mass spectroscopy, we further identified lysine residues within IDH2, which are the substrates of SIRT3. In summary, we demonstrate that 2HG levels arise from non-mutant IDH2 reductive function and decrease with increasing acetylation level. The newly identified lysine residues might apply in regulation of IDH2 function in response to metabolic perturbations occurring in cancer cells, such as glucose-free conditions.
See more in PubMed
Simic Z, Weiwad M, Schierhorn A, Steegborn C, Schutkowski M. The ɛ-Amino Group of Protein Lysine Residues Is Highly Susceptible to Nonenzymatic Acylation by Several Physiological Acyl-CoA Thioesters. ChemBioChem. 2015;16:2337–2347. PubMed
Vassilopoulos A, et al. SIRT3 Deacetylates ATP Synthase F 1 Complex Proteins in Response to Nutrient- and Exercise-Induced Stress. Antioxid. Redox Signal. 2014;21:551–564. PubMed PMC
Dikalova AE, et al. Sirt3 Impairment and SOD2 Hyperacetylation in Vascular Oxidative Stress and Hypertension. Circ. Res. 2017;121:564–574. PubMed PMC
Samant SA, et al. SIRT3 Deacetylates and Activates OPA1 To Regulate Mitochondrial Dynamics during Stress. Mol. Cell. Biol. 2014;34:807–819. PubMed PMC
Chen Y, Fu L L, Wen X, Wang X Y, Liu J, Cheng Y, Huang J. Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. Cell Death & Disease. 2014;5(2):e1047–e1047. PubMed PMC
Kim H-S, et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 2010;17:41–52. PubMed PMC
Yu W, et al. Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies. J. Biol. Chem. 2016;291:3268–3279. PubMed PMC
Li M, et al. Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis. Cancer Cell. 2019;35:916–931.e9. PubMed PMC
Yoo H, Antoniewicz MR, Stephanopoulos G, Kelleher JK. Quantifying reductive carboxylation flux of glutamine to lipid in a brown adipocyte cell line. J. Biol. Chem. 2008;283:20621–7. PubMed PMC
Ježek, P. 2-Hydroxyglutarate in Cancer Cells. Antioxid. Redox Signal. 10.1089/ars.2019.7902 (2020). PubMed PMC
Smolková Katarína, Dvořák Aleš, Zelenka Jaroslav, Vítek Libor, Ježek Petr. Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells. The International Journal of Biochemistry & Cell Biology. 2015;65:125–133. PubMed
Terunuma A, et al. MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J. Clin. Invest. 2014;124:398–412. PubMed PMC
Yu W, Dittenhafer-Reed KE, Denu JM. SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J. Biol. Chem. 2012;287:14078–86. PubMed PMC
Zou X, et al. SIRT3-Mediated Dimerization of IDH2 Directs Cancer Cell Metabolism and Tumor Growth. Cancer Res. 2017;77:3990–3999. PubMed PMC
Nadtochiy SM, et al. Potential mechanisms linking SIRT activity and hypoxic 2-hydroxyglutarate generation: no role for direct enzyme (de)acetylation. Biochem. J. 2017;474:2829–2839. PubMed PMC
Wagner GR, Payne RM. Widespread and enzyme-independent Nε-acetylation and Nε-succinylation of proteins in the chemical conditions of the mitochondrial matrix. J. Biol. Chem. 2013;288:29036–45. PubMed PMC
Pougovkina Olga, te Brinke Heleen, Ofman Rob, van Cruchten Arno G., Kulik Wim, Wanders Ronald J.A., Houten Sander M., de Boer Vincent C.J. Mitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidation. Human Molecular Genetics. 2014;23(13):3513–3522. PubMed
Fan J, et al. Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor Growth. Mol. Cell. 2016;64:859–874. PubMed PMC
Scott I, Webster BR, Li JH, Sack MN. Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1. Biochem. J. 2012;443:655–661. PubMed PMC
Scott I, et al. GCN5-like protein 1 (GCN5L1) controls mitochondrial content through coordinated regulation of mitochondrial biogenesis and mitophagy. J. Biol. Chem. 2014;289:2864–72. PubMed PMC
Webster BR, et al. Restricted mitochondrial protein acetylation initiates mitochondrial autophagy. J. Cell Sci. 2013;126:4843–4849. PubMed PMC
Wang L, et al. GCN5L1 modulates cross-talk between mitochondria and cell signaling to regulate FoxO1 stability and gluconeogenesis. Nat. Commun. 2017;8:523. PubMed PMC
Thapa D, et al. Acetylation of mitochondrial proteins by GCN5L1 promotes enhanced fatty acid oxidation in the heart. Am. J. Physiol. Circ. Physiol. 2017;313:H265–H274. PubMed PMC
Böhm G, Muhr R, Jaenicke R. Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng. Des. Sel. 1992;5:191–195. PubMed
Leonardi R, Subramanian C, Jackowski S, Rock CO. Cancer-associated isocitrate dehydrogenase mutations inactivate NADPH-dependent reductive carboxylation. J. Biol. Chem. 2012;287:14615–20. PubMed PMC
Xie X, et al. Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity. Structure. 2017;25:506–513. PubMed
Ahn B-H, et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. 2008;105:14447–14452. PubMed PMC
Hebert AS, et al. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell. 2013;49:186–99. PubMed PMC
Thapa D, et al. The protein acetylase GCN5L1 modulates hepatic fatty acid oxidation activity via acetylation of the mitochondrial β-oxidation enzyme HADHA. J. Biol. Chem. 2018;293:17676–17684. PubMed PMC
Anderson KA, Hirschey MD. Mitochondrial protein acetylation regulates metabolism. Essays Biochem. 2012;52:23–35. PubMed PMC
Osborne B, Bentley NL, Montgomery MK, Turner N. The role of mitochondrial sirtuins in health and disease. Free Radical Biology and Medicine. 2016;100:164–174. PubMed
Baeza J, Smallegan MJ, Denu JM. Mechanisms and Dynamics of Protein Acetylation in Mitochondria. Trends in Biochemical Sciences. 2016;41:231–244. PubMed PMC
Meyer JG, et al. Temporal dynamics of liver mitochondrial protein acetylation and succinylation and metabolites due to high fat diet and/or excess glucose or fructose. PLoS One. 2018;13:e0208973. PubMed PMC
Weinert BT, Moustafa T, Iesmantavicius V, Zechner R, Choudhary C. Analysis of acetylation stoichiometry suggests that SIRT3 repairs nonenzymatic acetylation lesions. EMBO J. 2015;34:2620–32. PubMed PMC
Hirschey MD, et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell. 2011;44:177–90. PubMed PMC
Cambronne XA, et al. Biosensor reveals multiple sources for mitochondrial NAD. Science (80-.). 2016;352:1474–1477. PubMed PMC
Kulkarni CA, Brookes PS. Cellular Compartmentation and the Redox/Nonredox Functions of NAD+ Antioxid. Redox Signal. ars. 2019;2018:7722. doi: 10.1089/ars.2018.7722. PubMed DOI PMC
Wise DR, et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of -ketoglutarate to citrate to support cell growth and viability. Proc. Natl. Acad. Sci. 2011;108:19611–19616. PubMed PMC
Mullen AR, et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature. 2012;481:385–8. PubMed PMC
Claros MG, Vincens P. Computational method to predict mitochondrially imported proteins and their targeting sequences. Eur. J. Biochem. 1996;241:779–86. PubMed
Cajka T, Smilowitz JT, Fiehn O. Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography–High-Resolution Mass Spectrometry Platforms. Anal. Chem. 2017;89:12360–12368. PubMed
Yang Y, et al. NAD+-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10. J. Biol. Chem. 2010;285:7417–7429. PubMed PMC
Chrastinová L, et al. A New Approach for the Diagnosis of Myelodysplastic Syndrome Subtypes Based on Protein Interaction Analysis. Sci. Rep. 2019;9:1–10. PubMed PMC